{
    "code": "02R00069",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02R00069",
    "time": "2023-09-14 21:43:27",
    "許可證字號": "衛署藥輸字第R00069號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/10",
    "發證\/登錄日期": "107\/07\/25",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "02900023",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHAS02R0006907",
    "中文品名": "氯化鉈ＴＬ－２０１注射劑",
    "英文品名": "THALLOUS CHLORIDE TL-201 INJECTION STERILE DIAGNOSTIC FOR INTRAVENOUS",
    "適應症": "心肌灌注造影及診斷、心肌梗塞及缺血性心臟病診斷",
    "劑型": "270注射劑",
    "包裝": "100公撮以下小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "THALLIUM TL-201",
    "限制項目": "02輸　入 15輸入須附同意書（每批輸入應附原子能委員會核准輸入證明書）",
    "申請商名稱": "臺灣新吉美碩股份有限公司",
    "申請商地址": "台北市大安區復興南路一段237號11樓",
    "主製造廠": [
        {
            "製造廠名稱": "LANTHEUS MEDICAL IMAGING",
            "製造廠廠址": "331 Treble Cove Rd., North Billerica, Massachusetts 01862, U.S.A",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "30063000002 Ｘ光檢驗用不透光製劑；專供病人用之診斷用試藥Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7804000800",
            "成分名稱": "THALLIUM TL-201",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MCI\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "Tl-201 注射劑仿單_R00069-107-07-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02R00069&Seq=002&Type=9"
        },
        {
            "title": "T1-201 外盒包裝(4)-104-10-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02R00069&Seq=004&Type=8"
        }
    ]
}